Careteq Ltd (ASX: CTQ) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Careteq Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$2.13 million
P/E Ratio
45.00
Dividend Yield
0.00%
Shares Outstanding
237.12 million
Earnings per share
0.000
Dividend per share
N/A
Year To Date Return
-18.18%
Earnings Yield
2.22%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Careteq Ltd (ASX: CTQ)
Latest News
Share Fallers
Why Accent, Careteq, Pro Medicus, and Xero shares are dropping
IPOs
This ASX share just dived 25% following its IPO. What happened?
CTQ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Careteq Ltd
Careteq Ltd provides Residential Medication Management Review and Home Medicines Review services as part of the Medication Management Programs, generating revenue from medication review, education, and support services. The company focuseson medication management and home care solutions to provide continuity of care and improve clinical outcomes for patients through Home Medication Reviews. Medication-related harm includes adverse drug reactions, medication errors, and complications that jeopardise patient safety and increase healthcare costs. The company operates in Australia.
CTQ Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 17 Feb 2026 | $0.01 | $0.00 | 0.00% | 543,393 | $0.01 | $0.01 | $0.01 |
| 16 Feb 2026 | $0.01 | $0.00 | 0.00% | 500,000 | $0.01 | $0.01 | $0.01 |
| 13 Feb 2026 | $0.01 | $0.00 | 0.00% | 671,768 | $0.01 | $0.01 | $0.01 |
| 12 Feb 2026 | $0.01 | $0.00 | 0.00% | 3,159,500 | $0.01 | $0.01 | $0.01 |
| 11 Feb 2026 | $0.01 | $0.00 | 0.00% | 1,784,971 | $0.01 | $0.01 | $0.01 |
| 10 Feb 2026 | $0.01 | $0.00 | 0.00% | 80,000 | $0.01 | $0.01 | $0.01 |
| 09 Feb 2026 | $0.01 | $0.00 | 0.00% | 4,640,336 | $0.01 | $0.01 | $0.01 |
| 06 Feb 2026 | $0.01 | $0.00 | 0.00% | 9,369,364 | $0.01 | $0.01 | $0.01 |
| 05 Feb 2026 | $0.01 | $0.00 | 0.00% | 14,510 | $0.01 | $0.01 | $0.01 |
| 04 Feb 2026 | $0.01 | $0.00 | 0.00% | 90,900 | $0.01 | $0.01 | $0.01 |
| 30 Jan 2026 | $0.01 | $0.00 | 0.00% | 44,590 | $0.01 | $0.01 | $0.01 |
| 29 Jan 2026 | $0.01 | $0.00 | 0.00% | 40,000 | $0.01 | $0.01 | $0.01 |
| 28 Jan 2026 | $0.01 | $0.00 | 0.00% | 77,006 | $0.01 | $0.01 | $0.01 |
| 27 Jan 2026 | $0.01 | $0.00 | 0.00% | 660,427 | $0.01 | $0.01 | $0.01 |
| 22 Jan 2026 | $0.01 | $0.00 | 0.00% | 505,099 | $0.01 | $0.01 | $0.01 |
| 21 Jan 2026 | $0.01 | $0.00 | 0.00% | 180,958 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 30 Jun 2025 | Mark Simari | Expiry | 3,000,000 | $33,000 |
Options expired.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Stephen John Munday | Non-Executive Director | Nov 2021 |
Mr Munday has over 40 years of business experience in Australia and North America, including more than 25 years working with or serving on boards across a range of organisations. He has held chief financial officer and company secretary roles in several listed companies, with responsibilities spanning marketing, business development, supply, commercial and financial management, and change management. Since 2015, he has worked in the healthcare sector and is currently involved in businesses supplying products, services, and technologies to the APAC healthcare and Australian aged care markets.
|
| Mr Mark Anthony Simari | Executive ChairmanExecutive Director | Jul 2024 |
Mr Simari as over 15 years of board experience across a range of organisations in the health industry. He played a key role in the growth of Paragon Care into a major independent healthcare supplier in Australia and New Zealand, developing a platform covering capital equipment, consumables, devices, and service and maintenance.
|
| Mr Brett Anthony Cheong | Non-Executive Director | Dec 2019 |
Mr Cheong has over 40 years of experience in the healthcare industry across all levels of management. He served as Managing Director of Axishealth Pty Ltd for nine years prior to its acquisition by Paragon Care. His experience spans sales and marketing, product design and development, manufacturing, and product sourcing.
|
| Mr David Lilja | Company Secretary |
-
|
|
| David Lilja | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| DMX Asset Management | 18,429,651 | 7.77% |
| Balmain Resources | 14,305,669 | 6.03% |
| Prince Holdings Qld Pty Ltd | 13,460,000 | 5.68% |
| Mr Mark Simari | 8,635,837 | 3.64% |
| JTO Flinders Pty Ltd | 6,280,000 | 2.65% |
| Growth Endeavours / Ascent Super Fund | 5,358,309 | 2.26% |
| HSBC Custody Nominees | 5,000,000 | 2.11% |
| Bnp Paribas Nominees Pty Ltd | 5,000,000 | 2.11% |
| HSBC Custody Nominees (Australia) Limited - A/C | 4,995,571 | 2.11% |
| Deakin University | 4,958,360 | 2.09% |
| Mr Kim Yeoh | 4,687,158 | 1.98% |
| Jt Mason Pty Ltd | 4,642,858 | 1.96% |
| Jmt Investment Group Vic Pty Ltd | 4,571,654 | 1.93% |
| Netwealth Investments Limited | 4,331,615 | 1.83% |
| Moonah Capital Pty Ltd | 4,250,000 | 1.79% |
| Ian Heraud Holdings Pty Ltd | 4,117,669 | 1.74% |
| Snowball Asset Management Pty Ltd | 4,074,008 | 1.72% |
| Abck Investments Trust | 3,454,335 | 1.46% |
| Troniq Pty Ltd | 3,400,000 | 1.43% |
| Mr Garry Crole | 3,278,320 | 1.38% |
